Dr. Alex Chenchik is president and chief scientific officer of Cellecta, Inc. based in Mountain View, California. Cellecta is focused on the development and application of next generation functional genomic technologies for the discovery of biomarkers, drug targets and the development of novel drugs. While at System Biosciences (SBI) as vice president of R&D, he developed a genetic screen technology with pooled lentiviral shRNA libraries in combination with a wide range of reporter cell lines. As director of the Gene Cloning and Analysis (GCA) group at Clontech Laboratories, he headed efforts to develop microarray and disease-profiling arrays for expression profiling, PCR-based technologies for gene cloning, and a subtraction-based approach for discovery of differentially expressed genes. Dr. Chenchik received his doctorate in Molecular Biology from the Institute of Molecular Biology, Moscow, Russia, and was a research scientist at the National Cardiology Research Center in Moscow. He has authored over 50 publications and is an inventor with more than a dozen issued patents.
